1. Home
  2. ESPR vs CTLP Comparison

ESPR vs CTLP Comparison

Compare ESPR & CTLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.72

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Logo Cantaloupe Inc.

CTLP

Cantaloupe Inc.

HOLD

Current Price

$10.61

Market Cap

781.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
CTLP
Founded
2008
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
898.5M
781.9M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ESPR
CTLP
Price
$3.72
$10.61
Analyst Decision
Buy
Hold
Analyst Count
7
3
Target Price
$6.86
N/A
AVG Volume (30 Days)
6.5M
814.0K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
371.48
EPS
N/A
0.80
Revenue
$303,802,000.00
$312,565,000.00
Revenue This Year
$25.45
$18.25
Revenue Next Year
N/A
$12.30
P/E Ratio
N/A
$13.23
Revenue Growth
2.83
12.94
52 Week Low
$0.69
$7.01
52 Week High
$4.13
$11.36

Technical Indicators

Market Signals
Indicator
ESPR
CTLP
Relative Strength Index (RSI) 56.14 49.71
Support Level $3.72 $10.57
Resistance Level $4.13 $10.65
Average True Range (ATR) 0.24 0.06
MACD -0.02 -0.00
Stochastic Oscillator 23.15 35.95

Price Performance

Historical Comparison
ESPR
CTLP

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About CTLP Cantaloupe Inc.

Cantaloupe Inc is a technology leader powering self-service commerce by offering one integrated solution for payments processing, logistics, and back-office management. The group offers a comprehensive suite of solutions, including micro-payment processing, self-checkout kiosks, mobile ordering, connected point-of-sale (POS) systems, and enterprise cloud software. Its product and services portfolio consists of Card Readers, Self-Service Kiosks, Smart Coolers, Seed Pick Easy, Cantaloupe Go, Cheq, Smart Lock Connect, and Vine Digital Studio. The company derives revenue streams from subscriptions, transaction processing, and equipment sales.

Share on Social Networks: